Medtronic has announced the launch of a new ECMO system called VitalFlow, which is a configurable one-system ECMO solution, built on simplicity and performance. The VitalFlow ECMO System bridges the gap between bedside care and intra-hospital transport, offering physicians and clinicians an easier, smarter ECMO experience.

The VitalFlow technology is the most innovative technology to-date from the Medtronic acquisition of MC3 Cardiopulmonary, which closed in March 2024. The acquisition marked the culmination of an eight-year partnership and distribution agreement with the Medtronic Cardiac Surgery business resulting in the introduction of seven new ECMO products in seven years.

Prior to the acquisition, MC3 Cardiopulmonary consistently developed and manufactured differentiated, high-quality ECMO products, which were exclusively distributed by Medtronic. These products, including catheters and oxygenators, are distinguished by their ability to simplify therapy and enhance ease of use. Additionally, the partnership has reliably supplied these long-term indicated products throughout the COVID pandemic and beyond.